Segal Trials Funding: How Much Did They Raise & Key Investors

How Much Did Segal Trials Raise?
Funding & Key Investors

Segal Trials has solidified its position in the clinical research landscape, securing a significant capital injection to bolster its operational capacity. With a cumulative financial backing reaching $350K, the organization continues to demonstrate robust growth trajectories within the competitive pharmaceutical services sector. The most recent financing event, characterized as a major strategic investment of $350K, underscores the firm's commitment to scaling its Phase I-IV research capabilities and expanding its footprint across South Florida and South Carolina.

This infusion of capital serves as a testament to the company's long-standing reputation for excellence in psychiatry, neurology, and women's health research. By leveraging this latest round of investment, Segal Trials is well-positioned to enhance its service offerings, which range from protocol design to complex bioanalytical lab analysis, ensuring that its sponsors receive high-quality, data-driven outcomes for their clinical development programs.

What is Segal Trials?

Segal Trials

Business Services

Research & Development

Healthcare Services

Founded in 1998, Segal Trials operates as a premier network of research sites dedicated to the advancement of medical science. The company distinguishes itself through a patient-centric approach and a deep-seated commitment to quality, having contributed to the development of 26 FDA-approved medications. Beyond its core clinical trial operations, the firm provides a comprehensive suite of services, including medical writing, project management, and clinical data monitoring. Its affiliation with Compass Health Systems further integrates its research efforts with behavioral health expertise, allowing for a unique, multidisciplinary approach to complex therapeutic areas such as insomnia and neurological disorders. As an innovator in the field, Segal Trials remains a critical partner for pharmaceutical sponsors seeking reliable, agile, and high-performing research infrastructure.

How much funding has Segal Trials raised?

Segal Trials has raised a total of $350K across 1 funding round:

2020

Debt

$350K

Debt (2020): $350K with participation from PPP

Key Investors in Segal Trials

PPP

Public-Private Partnership

What's next for Segal Trials?

Looking ahead, the strategic deployment of the $350K capital will likely focus on accelerating the firm's expansion into new therapeutic domains and upgrading its internal data management infrastructure. As the clinical research industry faces increasing pressure for faster, more accurate trial results, Segal Trials is poised to leverage its established vendor relationships and in-house expertise to capture additional market share. The organization's focus on community awareness and patient advocacy will remain a cornerstone of its growth strategy, ensuring a steady pipeline of volunteers for future studies. By maintaining its agile operational model, Segal Trials is set to navigate the evolving regulatory landscape while continuing to deliver high-impact results that improve patient outcomes on a global scale.

See full Segal Trials company page

See More Financial Insights